ArticleBriefings in bioinformatics2025
RMR-ICP: robust Mendelian randomization method accounting for idiosyncratic and correlated pleiotropy with applications to stroke outcomes.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivationMendelian randomization (MR) serves as a valuable tool for investigating causal relationships between exposures and disease outcomes in observational studies. However, MR methods, operating under classical assumptions, may yield biased estimates and inflated false-positive causal relationships when faced with realistic and complex correlated horizontal pleiotropy (CHP). While numerous MR methods have emerged to address CHP effects, limited methods can effectively handle relatively large direct effects, commonly known as idiosyncratic pleiotropy.
resultsTo address this gap, we propose an efficient and robust MR method to account for idiosyncratic and correlated pleiotropy, named RMR-ICP. Furthermore, Our method incorporates linkage disequilibrium structure using paralleled Gibbs sampling to enhance statistical power. The robustness and efficiency of our method are demonstrated through extensive simulation studies and applications. RMR-ICP is first used to analyze the effects of plasma proteins on stroke, followed by its application to conventional stroke risk factors. Our analysis reveals that Selectin E (SELE) exhibits a positive causal effect on the occurrence of any stroke. Only those specifically designed to account for idiosyncratic and CHP identified a significant positive causal effect of myeloperoxidase on ischemic stroke, with RMR-ICP providing stronger statistical evidence. Elevated Natriuretic Peptide B (BNP) levels specifically increase the risk of cardioembolic stroke (CES), though not with other stroke subtypes. This finding is consistent with previous studies suggesting that plasma BNP levels may help distinguish CES from other stroke types. Higher Waist-hip ratio (WHR) levels raise the risk across all stroke types. These findings provide new insights into identifying stroke-related risk factors. AVAILABILITY AND IMPLEMENTATION: RMR-ICP is publicly available at https://github.com/QingCheng0218/RMR.ICP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.